Repligen Corporation (RGEN)
NASDAQ: RGEN · Real-Time Price · USD
135.41
-1.03 (-0.75%)
At close: Feb 17, 2026, 4:00 PM EST
138.05
+2.64 (1.95%)
After-hours: Feb 17, 2026, 5:47 PM EST
Repligen Market Cap
Repligen has a market cap or net worth of $7.62 billion as of February 17, 2026. Its market cap has decreased by -18.79% in one year.
Market Cap
7.62B
Enterprise Value
7.56B
1-Year Change
-18.79%
Ranking
Category
Stock Price
$135.41
Market Cap Chart
Since December 1, 1998, Repligen's market cap has increased from $28.10M to $7.62B, an increase of 27,025.73%. That is a compound annual growth rate of 22.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 7.68B | -16.73% |
| Dec 31, 2025 | 9.22B | 14.38% |
| Dec 31, 2024 | 8.06B | -19.67% |
| Dec 29, 2023 | 10.04B | 6.78% |
| Dec 30, 2022 | 9.40B | -35.80% |
| Dec 31, 2021 | 14.64B | 45.21% |
| Dec 31, 2020 | 10.08B | 109.40% |
| Dec 31, 2019 | 4.82B | 108.18% |
| Dec 31, 2018 | 2.31B | 46.35% |
| Dec 29, 2017 | 1.58B | 51.58% |
| Dec 30, 2016 | 1.04B | 11.88% |
| Dec 31, 2015 | 932.00M | 43.85% |
| Dec 31, 2014 | 647.90M | 48.87% |
| Dec 31, 2013 | 435.20M | 122.72% |
| Dec 31, 2012 | 195.40M | 83.30% |
| Dec 30, 2011 | 106.60M | -26.18% |
| Dec 31, 2010 | 144.40M | 14.24% |
| Dec 31, 2009 | 126.40M | 7.21% |
| Dec 31, 2008 | 117.90M | -41.78% |
| Dec 31, 2007 | 202.50M | 137.12% |
| Dec 29, 2006 | 85.40M | -29.07% |
| Dec 30, 2005 | 120.40M | 39.03% |
| Dec 31, 2004 | 86.60M | -33.64% |
| Dec 31, 2003 | 130.50M | 57.04% |
| Dec 31, 2002 | 83.10M | 28.04% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| The Cooper Companies | 16.26B |
| Align Technology | 13.40B |
| Solventum | 13.10B |
| Baxter International | 10.18B |
| AptarGroup | 9.18B |
| Avantor | 6.27B |
| Bausch + Lomb | 6.03B |
| Merit Medical Systems | 4.84B |